Browsing Category

Top Industry News

7526 posts

Charles River To Sell CDMO & Cell Solutions Businesses  
By

By
Charles River Laboratories International, a CRO and CDMO, has agreed to sell certain of its European Discovery Services assets as well as its CDMO and Cell Solutions businesses in separate transactions.  In…

Global Briefs: Viatris, GSK, Novo Nordisk, Asahi Kasei & More 
By

By
A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Viatris, GSK, Asahi Kasei, Novo Nordisk, and Boehringer Ingelheim. Highlights below.   For the latest news roundup on small and Emerging Pharma…

Biotech Briefs: Angelini Pharma, Generate:Biomedicines & More 
By

By
The latest from small and Emerging Pharma companies featuring Angelini Pharma, Generate:Biomedicines and Quiver Bioscience.  For news on the large and mid-sized bio/pharmaceutical companies, see Global Briefs.  * Angelini Pharma, Quiver Bioscience in…

J&J Investing $1 Bn in New US Cell-Therapy Mfg Facility 
By

By
Johnson & Johnson (J&J) has announced a more than $1-billion investment to build a new cell-therapy manufacturing facility in Montgomery County, Pennsylvania. The announcement is part of the company’s previously announced $55-billion investment in US-based manufacturing, research…

Bayer Seeks $7.25-Bn Settlement for Roundup Litigation 
By

By
Monsanto, the crop-protection business of Bayer, has proposed a $7.25-billion US nationwide class settlement through a long-term claims program designed to resolve current and future claims over Roundup, a glyphosate-based herbicide, in which claimants allege Non-Hodgkin lymphoma injuries. The proposed…

Supplier News: Axplora, Experic, Recipharm & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Recipharm, Axplora, Experic, MGS and DFE Pharma.   Chemicals/Chemical API Manufacturing * Scinai Acquires Recipharm IsraelFormulation Development/Drug Product Manufacturing * Axplora To Expand Lyophilization Capacity for ADCs* DFE Pharma Launches Continuous Manufacturing Platform * Recipharm Expanding High-Potency…

Global Briefs: Stada, Sanofi, Novartis, Gilead & More 
By

By
A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Stada, Novartis, Gilead, Eli Lilly and Company, Sanofi, and GSK. Highlights below.   For the latest news roundup on small and Emerging Pharma…

Biotech Briefs: Korsana, PharmaEssentia, Innovacell & More 
By

By
The latest from small and Emerging Pharma companies featuring EIR Biopharma, EyePoint, Korsana Biosciences, Innovacell, PharmaEssentia, Rasayana Therapeutics/Theriva Biologics, and Sensei Biotherapeutics/Faeth Therapeutics.  For news on the large and mid-sized bio/pharmaceutical companies, see Global Briefs.  * EIR Biopharma Launches US IPO * EyePoint Names COO * Innovacell Launches IPO in…

Novartis Breaks Ground on New Research Center in US 
By

By
Novartis has broken ground on a new biomedical research center in San Diego, California. The facility represents another milestone in the company’s $23-billion US-based investments first announced in April 2025.  Once operational in…

Sanofi Completes $2.2-Bn Acquisition of Dynavax 
By

By
Sanofi has completed its $2.2-billion acquisition of Dynavax Technologies, a vaccines company. The deal was announced in January 2026.  Dynavax’s key product is its adult hepatitis B vaccine, Heplisav-B, which is marketed in the US and is differentiated by a two-dose regimen…